| 51 |
LECETAM 500 |
LEVETIRACETAM 500 MG |
FILM-COATED TABLETS |
ALU-ALU BLISTERPACK |
AS MONOTHERAPY IN THE TREATMENT OF PARTIAL ONSET SEIZURES WITH OR WITHOUT SECONDARY GENERALIZATION IN ADULTS AND ADOLESCENTS FROM 16 YEARS OF AGE WITH NEWLY DIAGNOSED EPILEPSY. |
No |
AI KEN PHARMA CO., LTD |
UNISON LABORATORIES CO., LTD |
THAILAND |
CERTIFICATE RELEASED |
12 I 4879/19 |
2023-02-02 |
2026-02-01 |
View |
| 52 |
LESFLAM |
DICLOFENAC POTASSIUM 50MG |
FILM-COATED TABLET |
ALU-PVC/PVDC BLISTER |
INDICATED FOR RHEUMATOID ARTHRITIS; OSTEOARTHRITIS AND ANKYLOSING SPONDYLITIS; PAIN; DYSMENORRHEA |
Yes |
AI KEN PHARMA CO., LTD |
UNISON LABORATORIES CO., LTD |
THAILAND |
CERTIFICATE RELEASED |
12 I 3266/08 |
2023-04-19 |
2026-04-18 |
View |
| 53 |
LEVOMET |
LEVODOPA 250 MG, CARBIDOPA MONOHYDRATE 27 MG EQ.TO CARBIDOPA 25 MG |
TABLET |
ALU-PVC/PVDC BLISTER |
TREATMENT OF IDIOPATHIC PARKINSON'S DISEASE, POSTENCEPHALITIC PARKINSONISM, OR SYMPTOMATIC PARKINSONISM, WHICH MAY FOLLOW INJURY TO THE NERVOUS SYSTEM BY CARBON MONOXIDE INTOXICATION OR MANGANESE INTOXICATION, TO PERMIT ACHIEVEMENT OF SYMPTOMATIC RELIEF WITH A LOWER DOSAGE OF LEVODOPA THAN WITH LEVODOPA ALONE. |
No |
AI KEN PHARMA CO., LTD |
UNISON LABORATORIES CO., LTD |
THAILAND |
CERTIFICATE RELEASED |
12 I 3264/08 |
2023-04-19 |
2026-04-18 |
View |
| 54 |
LEXEMIN 300 |
FENOFIBRATE 300MG |
CAPSULE |
ALU-ALU |
AS AN ADJUNCT TO DIET FOR THE TREATMENT OF ADULT PATIENTS WITH VERY HIGH SERUM TRIGLYCERIDE CONCENTRATION( TYPE IV AND V HYPERLIPIDEMIA) WHO HAVE NOT RESPONDED ADEQUATELY TO DIET WHO ARE AT RISK OF PANCREATITIS) |
No |
AI KEN PHARMA CO., LTD |
UNISON LABORATORIES CO., LTD |
THAILAND |
CERTIFICATE RELEASED |
12 I 3271/08 |
2023-04-19 |
2026-04-18 |
View |
| 55 |
LIVACT |
L-ISOLEUCINE 952 MG, L-LEUCINE 1904 MG, L-VALINE 1144 MG |
GRANULES |
SACHET |
FOR IMPROVEMENT OF HYPOALBUMINEMIA IN PATIENTS WITH DECOMPENSATED HEPATIC CIRRHOSIS PRESENTING WITH HYPOALBUMINEMIA DESPITE ADEQUATE DIETARY INTAKE |
No |
AI KEN PHARMA CO., LTD |
AJINOMOTO CO., INC.TOKAI PLANT |
JAPAN |
CERTIFICATE RELEASED |
03 I 4378/18 |
2024-09-25 |
2029-09-24 |
View |
| 56 |
LONSURF FILM-COATED TABLET 15 MG/6.14 MG |
TRIFLURIDINE 15 MG, TIPIRACIL 6.14 MG (TIPIRACIL HYDROCHLORIDE 7.065 MG) |
FILM COATED TABLET |
BLISTERPACK |
FOR THE TREATMENT OF PATIENTS WITH UNRESECTABLE ADVANCED OR RECURRENT COLORECTAL CANCER |
No |
AI KEN PHARMA CO., LTD |
TAIHO PHARMACEUTICAL CO.,LTD KITAJIMA PLANT |
JAPAN |
CERTIFICATE RELEASED |
08 I 5120/21 |
2024-07-09 |
2027-07-08 |
View |
| 57 |
LONSURF FILM-COATED TABLET 20 MG/8.19 MG |
TRIFLURIDINE 20 MG, TIPIRACIL 8.19 MG (TIPIRACIL HYDROCHLORIDE 9.42MG) |
FILM COATED TABLET |
BLISTERPACK |
FOR THE TREATMENT OF PATIENTS WITH UNRESECTABLE ADVANCED OR RECURRENT COLORECTAL CANCER |
No |
AI KEN PHARMA CO., LTD |
TAIHO PHARMACEUTICAL CO.,LTD KITAJIMA PLANT |
JAPAN |
CERTIFICATE RELEASED |
08 I 5121/21 |
2024-07-09 |
2027-07-08 |
View |
| 58 |
LOSU-2 |
GLIMEPIRIDE MICRONIZED 2 MG |
TABLET |
ALU-PVC/PVDC |
TREATMENT OF TYPE 2 DIABETES MELLITUS, WHEN DIET, PHYSICAL EXERCISE AND WEIGHT REDUCTION ALONE ARE NOT ADEQUATE. |
No |
AI KEN PHARMA CO., LTD |
UNISON LABORATORIES CO., LTD |
THAILAND |
CERTIFICATE RELEASED |
04 I 4656/19 |
2022-08-05 |
2025-08-04 |
View |
| 59 |
LOSU-3 |
GLIMEPIRIDE MICRONIZED 3 MG |
TABLET |
ALU-PVC/PVDC |
TREATMENT OF TYPE 2 DIABETES MELLITUS, WHEN DIET, PHYSICAL EXERCISE AND WEIGHT REDUCTION ALONE ARE NOT ADEQUATE. |
No |
AI KEN PHARMA CO., LTD |
UNISON LABORATORIES CO., LTD |
THAILAND |
CERTIFICATE RELEASED |
04 I 4657/19 |
2022-08-05 |
2025-08-04 |
View |
| 60 |
LOSU-4 |
GLIMEPIRIDE MICRONIZED 4 MG |
TABLET |
ALU-PVC/PVDC |
TREATMENT OF TYPE 2 DIABETES MELITUS,TREATMENT OF TYPE 2 DIABETES MELLITUS, WHEN DIET, PHYSICAL EXERCISE AND WEIGHT REDUCTION ALONE ARE NOT ADEQUATE. |
No |
AI KEN PHARMA CO., LTD |
UNISON LABORATORIES CO., LTD |
THAILAND |
CERTIFICATE RELEASED |
10 I 4814/19 |
2022-08-05 |
2025-08-04 |
View |
